XML 11 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2023 $ 32,331     $ 288,036 $ (256,085) $ 380
Beginning balance (in shares) at Dec. 31, 2023     1,084,509      
Stock-based compensation expense 2,250     2,250    
Issuance of common stock in connection with vesting of restricted stock units 5     5    
Issuance of common stock in connection with vesting of restricted stock units, (in shares)     333      
Other comprehensive income (loss), net (183)         (183)
Net loss (10,815)       (10,815)  
Ending balance at Jun. 30, 2024 23,588     290,291 (266,900) 197
Ending balance (in shares) at Jun. 30, 2024     1,084,842      
Beginning balance at Mar. 31, 2024 28,159     289,395 (261,562) 326
Beginning balance (in shares) at Mar. 31, 2024     1,084,509      
Stock-based compensation expense 891     891    
Issuance of common stock in connection with vesting of restricted stock units 5     5    
Issuance of common stock in connection with vesting of restricted stock units, (in shares)     333      
Other comprehensive income (loss), net (129)         (129)
Net loss (5,338)       (5,338)  
Ending balance at Jun. 30, 2024 23,588     290,291 (266,900) 197
Ending balance (in shares) at Jun. 30, 2024     1,084,842      
Beginning balance at Dec. 31, 2024 $ 15,831 $ 1,360   291,898 (277,524) 97
Beginning balance (in shares) at Dec. 31, 2024     1,316,989      
Beginning balance (in shares) at Dec. 31, 2024 161 161        
Stock-based compensation expense $ 351     351    
Conversion of Series A Preferred Stock   $ (19)   19    
Conversion of Series A Preferred Stock (in shares)   (2) 2,201      
Issuance of common stock in connection with vesting of restricted stock units 29     29    
Issuance of common stock in connection with vesting of restricted stock units, (in shares)     5,370      
Other comprehensive income (loss), net 712         712
Net loss $ (5,970)       (5,970)  
Ending balance (in shares) at Jun. 30, 2025 159 159        
Ending balance at Jun. 30, 2025 $ 10,953 $ 1,341   292,297 (283,494) 809
Ending balance (in shares) at Jun. 30, 2025     1,324,560      
Beginning balance at Mar. 31, 2025 13,709 $ 1,360   292,106 (280,057) 300
Beginning balance (in shares) at Mar. 31, 2025     1,322,359      
Beginning balance (in shares) at Mar. 31, 2025   161        
Stock-based compensation expense 172     172    
Conversion of Series A Preferred Stock   $ (19)   19    
Conversion of Series A Preferred Stock (in shares)   (2) 2,201      
Other comprehensive income (loss), net 509         509
Net loss $ (3,437)       (3,437)  
Ending balance (in shares) at Jun. 30, 2025 159 159        
Ending balance at Jun. 30, 2025 $ 10,953 $ 1,341   $ 292,297 $ (283,494) $ 809
Ending balance (in shares) at Jun. 30, 2025     1,324,560